CPRX - Company ID 0001369568
The table below shows CATALYST PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $755.86M | $689.89M | $652.80M | $580.66M | $442.33M | $375.69M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $130.83M | $106.41M | $65.86M | $71.27M | $58.27M | $57.17M |
| Inventory | $34.93M | $28.03M | $18.65M | $19.78M | $20.02M | $18.01M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $940.39M |
| $852.45M |
| $758.74M |
| $685.72M |
| $539.00M |
| $474.43M |
| Property, plant & equipment | $994.00K | $1.08M | $1.15M | $1.24M | $1.38M | $1.23M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.15B | $1.05B | $971.91M | $908.87M | $772.01M | $706.36M |
| Accounts payable | $7.15M | $9.10M | $5.53M | $11.20M | $11.56M | $7.12M |
| Total current liabilities | $132.40M | $128.74M | $113.01M | $111.65M | $105.39M | $92.32M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $134.91M | $131.36M | $115.89M | $114.59M | $111.07M | $97.70M |
| Retained earnings | $523.35M | $446.79M | $394.01M | $341.90M | $229.22M | $185.34M |
| Total equity | $1.01B | $920.25M | $856.03M | $794.28M | $660.94M | $608.65M |